India's Wockhardt jumps; US FDA accepts application for antibiotic Zaynich
** India's Wockhardt WCKH.NS surges 11.8% to 1,380.80 rupees ** Drugmaker says US FDA accepts its new drug application for antibiotic Zaynich ** Zaynich also gets fast track designation by US FDA, assigning priority to its application's review ** YTD, WCKH down 2.6% (Reporting by Kashish Tandon in Bengaluru) ((Kashish.tandon@thomsonreuters.com))
Recent news on Wockhardt
See all newsBrief: Wockhardt Says Customs Authority Imposes 50 Million Rupees Penalty And 100 Million Rupees Redemption Fine On Co
Brief: Wockhardt Limited June-Quarter Consol Net Profit 1.06 Billion Rupees
India's Wockhardt gains after marketing authorization for antibiotic ZAYNICH
Brief: Wockhardt Says Indian Drug Regulator Grants Marketing Authorization To Co's Zaynich
India's Wockhardt hits 7‑month high after swinging to profit in fourth quarter